<DOC>
	<DOC>NCT00949130</DOC>
	<brief_summary>The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.</brief_summary>
	<brief_title>Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Streptogramin A</mesh_term>
	<criteria>Diagnosed with acute bacterial skin and skin structure infection (ABSSSI) with at least 3 signs or symptoms Uncomplicated acute bacterial skin and skin structure infections ABSSSI suspected or proven to be due to Gram negative and/or anaerobic pathogens Pregnant or lactating women Inadequately controlled diabetes mellitus Inadequately controlled arterial hypertension Moderatetosevere renal impairment Moderatetosevere liver disease Conditions associated with immunodeficiency Known hypersensitivity or any contraindication for the use of any of the 2 study drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>